Fingerprint
Dive into the research topics of 'Chemoradionuclide therapy with <sup>186</sup>Re-labeled liposomal doxorubicin: Toxicity, dosimetry, and therapeutic response'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin: Toxicity, dosimetry, and therapeutic response
Anuradha Soundararajan, Ande Bao, William T. Phillips, Linda M. McManus, Beth A. Goins
Research output: Contribution to journal › Article › peer-review
14
Scopus
citations